Bayer

Bayer

Chemische productie

Leverkusen, North Rhine-Westphalia 5.609.704 volgers

Over ons

Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by empowering everyday health, improving approaches to patient care, and finding better ways to nourish our communities around the world. Data Privacy Statement & Imprint: https://www.bayer.com/en/glob-li-bayer-en-dps-imprint.aspx

Branche
Chemische productie
Bedrijfsgrootte
Meer dan 10.000 werknemers
Hoofdkantoor
Leverkusen, North Rhine-Westphalia
Type
Naamloze vennootschap
Specialismen
Pharmaceuticals , Consumer Health, Crop Science, Life Sciences, Research, Innovation, Sustainability, Health Care, Digital Farming, Food Security en Science For Better

Locaties

Medewerkers van Bayer

Updates

  • Bayer heeft dit gerepost

    Organisatiepagina weergeven voor Bayer, afbeelding

    5.609.704 volgers

    📈 Estima-se que 1,1 a 1,2M mulheres passam hoje pelo processo de Menopausa. Uma fase em que todas as mulheres irão passar mais de 30% da sua vida*. ➡️ 9 em cada 10* destas mulheres têm sintomas mas desconhecem-nos e sabemos que muitos destes sintomas têm impacto na vida profissional e pessoal, podendo afetar também a saúde mental. 🔛 Porque sabemos que a desinformação acerca da menopausa é um dos problemas mais iminentes, quisémos trazer o tema a debate e, no passado dia 16 de outubro, reunimos um painel de ilustres convidadas para debater o impacto que a menopausa tem nos dias de hoje, como são geridos atualmente os sintomas e de que forma as empresas se podem adaptar para melhor prepararem os seus colaboradores (homens e mulheres) para esta fase. 🗨️ Contámos com a presença da Dra. Ana Figueiredo, Ginecologista e Obstetra do HBA, que acompanha diariamente mulheres em menopausa. A Dra Cristina Mesquita De Oliveira, Fundadora e Presidente da Associação Portuguesa de Menopausa (VIDAs) cuja a missão é lutar pelos direitos das mulheres em menopausa e Esther Farreny, HR Talent Lead PH da Bayer Iberia, que trouxe à discussão o impacto que a menopausa tem na carreira e o papel que as empresas devem desempenhar nesta fase da vida das mulheres, uma vez que há cada vez mais mulheres em idade ativa a passar pela menopausa. 📅 Hoje, dia 18 de outubro, assinala-se o 𝗗𝗶𝗮 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝗰𝗶𝗼𝗻𝗮𝗹 𝗱𝗮 𝗠𝗲𝗻𝗼𝗽𝗮𝘂𝘀𝗮 e revela-se essencial e urgente falarmos e conhecermos esta fase da vida das mulheres. 𝗠𝗲.𝗡𝗼.𝗣𝗮 ⏸️ 𝘀𝗲 personifica o compromisso e missão que a Bayer assume em continuar ao lado da mulher em mais uma fase da sua vida e que reforça o já longo legado na área da Saúde da Mulher. *𝘍𝘰𝘯𝘵𝘦𝘴: 𝘌𝘴𝘵𝘶𝘥𝘰𝘴 “𝘋𝘢𝘳 𝘰𝘶𝘷𝘪𝘥𝘰𝘴 𝘦 𝘷𝘰𝘻 à 𝘔𝘦𝘯𝘰𝘱𝘢𝘶𝘴𝘢” 𝘈𝘣𝘳𝘪𝘭, 2024 – 𝘈𝘨𝘦𝘢𝘴 𝘦 “𝘔𝘦𝘯𝘰𝘱𝘢𝘶𝘴𝘢: 𝘤𝘰𝘮𝘰 é 𝘷𝘪𝘷𝘪𝘥𝘢 𝘱𝘦𝘭𝘢𝘴 𝘮𝘶𝘭𝘩𝘦𝘳𝘦𝘴 𝘦𝘮 𝘗𝘰𝘳𝘵𝘶𝘨𝘢𝘭” 𝘞𝘦𝘭𝘭𝘴, 𝘑𝘶𝘯𝘩𝘰 2024

    • Geen alternatieve tekst opgegeven voor deze afbeelding
    • Geen alternatieve tekst opgegeven voor deze afbeelding
    • Geen alternatieve tekst opgegeven voor deze afbeelding
    • Geen alternatieve tekst opgegeven voor deze afbeelding
    • Geen alternatieve tekst opgegeven voor deze afbeelding
  • Organisatiepagina weergeven voor Bayer, afbeelding

    5.609.704 volgers

    Malnutrition is a critical global issue, especially for women and children in underserved communities. Climate change could cause an additional 40 million children to be stunted and 28 million to suffer from wasting by 2050. The health and climate crises are deeply linked, particularly in poorer equatorial regions. Investing in nutrition is key to combating these impacts. We are actively addressing these challenges through our Nutrient Gap Initiative (NGI), focusing on providing essential nutrients to those who need them most, from nutritious food to safety net supplementation. We’re thrilled NGI has been recognized with a “high commendation” at the Reuters Sustainability Awards for our Social Impact. Together, we can make a difference. We will continue to work towards #HealthForAll and #HungerForNone, ensuring that no one is left behind in the fight against malnutrition.

    • Geen alternatieve tekst opgegeven voor deze afbeelding
  • Organisatiepagina weergeven voor Bayer, afbeelding

    5.609.704 volgers

    Can AI truly revolutionize healthcare? The answer is yes! By integrating AI in radiology, we’re seeing faster, more accurate diagnoses, enhancing patient care. In this Science Is Boss episode, CEO Bill Andersonchatted with Jamie Chow, a former radiologist, who led the clinical team at Blackford, a Bayer-owned top provider of AI solutions for health care systems around the globe. Here are just a few key benefits Jamie highlighted: - Reduced wait times for diagnoses 🕒 - Enhanced accuracy and early detection 🔬 - Less pressure on overworked clinicians 👩⚕️👨⚕️ Watch the full episode of Science is Boss (video link in first comment) to learn how AI is transforming the way we diagnose! The future of healthcare is here. #AIinHealthcare #Radiology #HealthcareInnovation

  • Organisatiepagina weergeven voor Bayer, afbeelding

    5.609.704 volgers

    Who remembers the first data centers at Bayer 50 years ago? Back in the 1970s, being an operator was a highly skilled job. These pioneers maximized the potential of mainframe computers by meticulously analyzing processes and ensuring optimal system utilization. They tackled challenges such as resource interruptions and deadlocks, often manually starting processes to keep things running smoothly. Fast forward today: we are now managing our work with the cutting-edge of handheld devices! Digitalization and innovation have always been at the heart of our sophisticated IT infrastructure. At Bayer, our unwavering commitment to security and risk management has created a unique IT landscape, offering exciting development opportunities. Our mission “Health for All, Hunger for none” sets us apart in the global marketplace, with innovations that directly impact the work of our customers and employees. Many thanks to our dedicated Heritage Communications team for preserving these great visual treasures that remind us of our roots and the core values that remain unchanged. Do you love old photos as much as we do? Stay tuned for more captivating glimpses of our past and present! Join us on this exciting journey. #BayerCareer #BeBayer #TeamBayer

  • Organisatiepagina weergeven voor Bayer, afbeelding

    5.609.704 volgers

    🌍✨ We look at the world and see infinite opportunities to make things better. From new means of rice production, more individualized ways to look after our health, to new treatments for some of the world's worst diseases. That's what we mean with our mission #Healthforall and #Hungerfornone. We won't stop! Check out this #InfiniteZoom video for a look at the ways #TeamBayer is trying to make the world a better place.

  • Organisatiepagina weergeven voor Bayer, afbeelding

    5.609.704 volgers

    Every woman encounters transitions throughout her life, which can have significant consequences for her health and wellbeing. Menopause is such a major transition, potentially affecting health, quality of life and productivity at work. At #TeamBayer, we are investing in novel approaches for menopause management, aiming to expand treatment choices and address the diverse needs of different women during this pivotal time. That is why we are excited to announce today the application for marketing authorization (MMA) to the European Medicines Agency (EMA) of our investigational menopause treatment. With this submission, we hope to build on providing women with more therapeutic choices across their lifetime. Our goal is to offer a brighter future, helping women manage their individual symptoms and live well with menopause. As a global leader in Women's Healthcare, we are committed to continuing to develop a range of innovative solutions, supporting the girls and women of today and tomorrow in living their life to the fullest. Learn more: bit.ly/News_Bayer #WomensHealth #HealthForAll #HungerForNone

  • Organisatiepagina weergeven voor Bayer, afbeelding

    5.609.704 volgers

    AI is a revolutionary tool, whether it’s being used in our labs or by the farmers we serve. But it’s only half of the picture. While AI is helping the 🧑🔬humans🧑🔬 at Bayer, it’s their human touch that makes the biggest impact. In this way AI allows us to streamline our expertise and bring new solutions to farmers faster than before — for example AI helped us develop the first new mode of action for use on pre-emergent weeds in 30 years. How are you using AI to transform your work? Share your thoughts in the comments.

  • Organisatiepagina weergeven voor Bayer, afbeelding

    5.609.704 volgers

    Aging is inevitable. Therefore, it is important to ask ourselves: What will society look like 30 years from now? What challenges will we be facing, and what can we be doing now to ensure we can meet the needs of our aging society? The topic of #HealthyAging is central to how companies like Bayer are taking a forward-thinking strategic approach to cutting-edge innovations that can contribute to the healthy workforce, economy, and society of the future. Bayer | Pharmaceuticals is co-hosting the #SilverEconomyForum with the Global Coalition on Aging in Berlin on October 16th to discuss just how to do that. Learn more and register for the virtual event here: http://spr.ly/6047USacZ #HealthForAll #HungerForNone #SilverSociety

    • Geen alternatieve tekst opgegeven voor deze afbeelding
  • Organisatiepagina weergeven voor Bayer, afbeelding

    5.609.704 volgers

    Meet Shinya Yamanaka, world renowned stem cell researcher and Nobel Prize laureate. His novel approach to cell therapy holds promising potential for treating cancer, Parkinson’s and eye diseases. Building on Yamanaka’s discovery, BlueRock Therapeutics is developing an investigational cell therapy for patients with primary photoreceptor diseases, an inherited subgroup of retinal disorders that lead to irreversible vision loss in children and adults. Just last month, the FDA cleared BlueRock to begin a phase 1/2a clinical trial in the U.S. Want the inside scoop on how the cell therapy field is changing medicine as we know it? Read what Shinya Yamanaka and Juergen Eckhardt discussed over on Forbes: https://lnkd.in/ezm_Jp2X

Gerelateerde pagina’s

Vergelijkbare pagina’s

Door vacatures bladeren

Financiering

Bayer 2 rondes in totaal

Laatste ronde

Toekennen

US$ 12.000.000,00

Bekijk meer informatie over Crunchbase